Electronic Transmission of Laboratory and Adherence Records of Heart Failure Patients to General Practitioners Screen

NCT04326101 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2021-11-29

No results posted yet for this study

Summary

Patients with heart failure (HF) need multiple guideline-directed medications to control the systolic and/or diastolic ventricular dysfunction. Laboratory measure the biomarker NT-proBNP (N-terminal pro-B type natriuretic peptide) to support clinical decision and to guide treatment at every stage of HF. Many patients (including HF patients) do not follow therapeutic recommendations. Electronic monitoring of medication intake gives precise information over time and is the gold standard to unveil inappropriate behaviour. Electronic Health Records (EHR) are repository of patient health data in digital format and are mostly locally configured in medical practices.

We aim to transmit laboratory results of NT-proBNP and estimates of medication adherence into the EHR system of primary care providers, with the objective to guide treatment and dose adjustment of multiple medications in patients with HF. Our project is \*not\* to develop a telemonitoring system.

Conditions

Interventions

OTHER

Transmission of adherence records

Electronic transmission of patient adherence records by pharmacists into medical EHR (Electronic Health Records)

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Kurt E Hersberger, Prof · University of Basel

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2021-09-27
Completion
2021-09-27

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04326101 on ClinicalTrials.gov